Featured Chrome Extensions:

Casey IRACs are produced by an AI that analyzes the opinion’s content to construct its analysis. While we strive for accuracy, the output may not be flawless. For a complete and precise understanding, please refer to the linked opinions above.

Keywords

plaintiffpatent
plaintiffpatent

Related Cases

Association for Molecular Pathology v. U.S. Patent and Trademark Office, 689 F.3d 1303, 103 U.S.P.Q.2d 1681
View Case »
Orr v. Shicker, 953 F.3d 490
View Case »
Beech v. FV WISHBONE, 113 F.Supp.3d 1203
View Case »
MTW Inv. Co. v. Alcovy Properties, Inc., 273 Ga.App. 830, 616 S.E.2d 166, 05 FCDR 1921
View Case »
Beverly Glen Music, Inc. v. Warner Communications, Inc., 178 Cal.App.3d 1142, 224 Cal.Rptr. 260
View Case »
Justia Law Link
LexisNexis Link
Westlaw Link
CourtListener Link
Oyez Link

Hoffman-La Roche, Inc. v. Promega Corp., 319 F.Supp.2d 1011

Facts

The plaintiffs owned two patents concerning the polymerase chain reaction (PCR) and a patent on a thermostable DNA polymerase derived from Thermus aquaticus. The case arose when the plaintiffs accused the licensee of infringing these patents and breaching the licensing agreement. The court previously found that the '818 patent was unenforceable due to inequitable conduct, while the related '195 and '202 patents were not affected by this ruling. The licensee sought various remedies, including holding the '818 patent unenforceable again and dismissing claims related to the other patents.

The plaintiffs owned two patents concerning the polymerase chain reaction (PCR) and a patent on a thermostable DNA polymerase derived from Thermus aquaticus.

Issue

The main legal issues included whether the '818 patent should be held unenforceable due to inequitable conduct and whether the related '195 and '202 patents should also be rendered unenforceable under the doctrines of infectious unenforceability and unclean hands.

The main legal issues included whether the '818 patent should be held unenforceable due to inequitable conduct and whether the related '195 and '202 patents should also be rendered unenforceable under the doctrines of infectious unenforceability and unclean hands.

Rule

The court applied a two-step analysis for inequitable conduct, requiring clear and convincing evidence of a misrepresentation or omission of a material fact with intent to deceive the PTO, followed by an equitable determination of whether the equities warrant a conclusion of inequitable conduct.

The court applied a two-step analysis for inequitable conduct, requiring clear and convincing evidence of a misrepresentation or omission of a material fact with intent to deceive the PTO, followed by an equitable determination of whether the equities warrant a conclusion of inequitable conduct.

Analysis

The court found that the plaintiffs had committed inequitable conduct during the prosecution of the '818 patent, as evidenced by multiple misstatements made with intent to deceive the PTO. The court concluded that these misstatements were material to the prosecution of the patent and justified holding the '818 patent unenforceable. However, the court determined that the relationship between the '818 patent and the '195 and '202 patents did not meet the standard for infectious unenforceability, as the misrepresentations were not sufficiently related to the prosecution of the latter patents.

The court found that the plaintiffs had committed inequitable conduct during the prosecution of the '818 patent, as evidenced by multiple misstatements made with intent to deceive the PTO.

Conclusion

The court held the '818 patent unenforceable due to inequitable conduct and dismissed the plaintiffs' claims of direct, induced, and contributory infringement of that patent. However, it denied the request to hold the '195 and '202 patents unenforceable.

The court held the '818 patent unenforceable due to inequitable conduct and dismissed the plaintiffs' claims of direct, induced, and contributory infringement of that patent.

Who won?

The prevailing party was the licensee, as the court granted their request to hold the '818 patent unenforceable and dismissed certain claims against them, while denying the plaintiffs' claims for remedies.

The prevailing party was the licensee, as the court granted their request to hold the '818 patent unenforceable and dismissed certain claims against them.

You must be